logo
Select company
Select metric
-5041.17%EBIT Margin
VS
Market
2
Sector
9
Industry
16
History
40
$ 7.67Close
$ 4.25 - $ 27.58 52-Week Range
Ticker Information

Ticker

LYRA

Company Name

LYRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LYRA THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LYRA - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -38.82M-5041.17%$ 770K
3/31/2025$ -79.5M-6708.95%$ 1.19M
12/31/2024$ -93.4M-6088.4%$ 1.53M
9/30/2024$ -97.56M-6632.36%$ 1.47M
6/30/2024$ -101.33M-5567.64%$ 1.82M
3/31/2024$ -68.82M-4096.31%$ 1.68M
12/31/2023$ -62.62M-4019.32%$ 1.56M
9/30/2023$ -61.7M-4336.19%$ 1.42M
6/30/2023$ -60.84M-4913.97%$ 1.24M
3/31/2023$ -59.59M-4566.67%$ 1.3M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LYRA THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, LYRA THERAPEUTICS INC's average EBIT % has been -21241.99%.
  • The median EBIT % for LYRA THERAPEUTICS INC during this period was -4740.32%
  • LYRA THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -755.89%.
  • The lowest EBIT % recorded by LYRA THERAPEUTICS INC in the same timeframe -263692.86%

LYRA THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
APRE : APREA THERAPEUTICS INC -1766.47%BRTX : BIORESTORATIVE THERAPIES INC -1771.91%ERNA : ERNEXA THERAPEUTICS INC -7890.57%VYNE : VYNE THERAPEUTICS INC -8096.85%SXTP : 60 DEGREES PHARMACEUTICALS INC -918.16%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%ICU : SEASTAR MEDICAL HOLDING CORP -1909.79%RLYB : RALLYBIO CORP -5473.32%IBIO : IBIO INC -4541.25%CODX : CO-DIAGNOSTICS INC -3582.18%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for LYRA THERAPEUTICS INC is calculated as follows: EBIT [ $ -22.13M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

LYRA - EBIT Margin, Last 5 years

-263692.86%

Minimum

Sep 30, 2021

-755.89%

Maximum

Mar 31, 2022

-21241.99%

Average

-4740.32%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%